Bon Natural Life Limited Provides Update on Its Expansion Project
XI'AN, China, Oct. 1, 2022 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that there will be a delay to the initial production target of Q4 2022 for its third production site – Yumen Plant to May 2023....
Concord Medical Announces Changes in Management
BEIJING, Oct. 1, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced changes in its management. Mr. Yaw Kong Yap...
Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023
GOTHENBURG, Sweden, Oct.1, 2022 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company's Annual General Meeting 2023 has been appointed. At the Annual General Meeting held on 27th of April 2022, it was resolved to adopt instructions...
Infinitus Products Received the Hong Kong Q-Mark Certificate
GUANGZHOU, China, Sept. 30, 2022 /PRNewswire/ -- The Q-Mark 43rd Anniversary cum Presentation Ceremony has been successfully held at the Hong Kong Convention and Exhibition Centre on 2 September 2022. Nine Infinitus Products Have Received the Hong Kong Q-Mark Product Certification. The Hong Kong Q-Mark Product Scheme companies with an effective quality management system that ensures production...
Wel-Bloom Launches Delicious Jelly Supplement Edibles, A New Milestone in Dietary Supplement Manufacturer
TAIPEI, Sept. 30, 2022 /PRNewswire/ -- Taiwan based dietary supplement manufacturer Wel-Bloom has launched its revolutionary form technology -- Nutri-Crypt® and Nu-fusion™, as well as its efficacy platform centered on cell-based assays at its recent Innovative Technology Online Forum. The event held in July this year saw world-renowned biomedical scientists, entrepreneurs, and investors gather to grasp the business opportunities of...
YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP.
Transaction values YS Biopharma at pre-money equity value of $834 million Certain investors ("Forward Purchase Investors") are expected to invest $30 million in a private placement concurrently with the closing of the business combination transaction pursuant to certain forward purchase agreements Up to 2,732,325 incentive bonus shares, including up to 1,285,800...
First Patient in New Zealand Dosed with Illuccix® – Telix’s Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose in New Zealand of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known as 68Ga-PSMA-11 injection. As Illuccix rolls out to positron emission tomography (PET) sites...
Doxy.me extends telemedicine’s reach to 88% of the world’s population
Doxy.me adds over 100 languages, live interpreters, and global currencies to overcome barriers to telemedicine around the world. CHARLESTON, S.C., Sept. 30, 2022 /PRNewswire/ -- Doxy.me, the web-based telemedicine platform on a mission to make telemedicine available to all, is expanding its capabilities to 88% of the world's population. Less than...
XSENSOR Earns the Frost & Sullivan 2022 Technology Innovation Leadership Award for Intelligent Dynamic Sensing Systems
Delivers innovative pressure measurement solutions to the world's most demanding customers. SAN ANTONIO, Sept. 29, 2022 /PRNewswire/ -- Based on its recent analysis of the sensor technology in the medical devices market, Frost & Sullivan recognizes XSENSOR Technology Corporation with the 2022 North America Technology Innovation Leadership Award. XSENSOR develops innovative sensing solutions for a spectrum of industries, including healthcare, engineering,...
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022
Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures optimized manufacturability of bispecific antibodies. DEVELOPICK™ provides early insight and selection guidance to save time and cost to maximize efficiency. INCHEON, South Korea, Sept. 29, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a world-leading contract development and manufacturing...
